loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 206623 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Dr. Reddy's Laboratories

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    Key Products KEY PRODUCTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 DR REDDYS LABS SA (1)

    filter

    01 CAPSULE, DELAYED RELEASE;ORAL (1)

    filter

    01 RX (1)

    filter

    01 BUDESONIDE (1)

    filter

    01 No (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    BUDESONIDE

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE, DELAYED R...
    3MG
    2016-04-08
    206623
    BUDESONIDE
    RX
    No
    AB
    Dr Reddy Company Banner

    CPhI China

    Booth #E1H28

    envelop Contact Supplier

    Looking for FDA Orange Book APPLICATION 206623

    Looking for FDA Orange Book APPLICATION 206623 1

    19

    Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    One of their notable products is BUDESONIDE, with a corresponding application number 206623.

    Regulatory Information RX

    With a dosage strength 3MG

    Dosage Form Route CAPSULE, DELAYED RELEASE; ORAL

    Reference Listed Drug No

    Approved since 2016-04-08

    Therapeutic Equivalence (TE) Code AB

    Post Enquiry
    POST ENQUIRY